Natural Health Science Introduces New Clinical Research on Pycnogenol® at SupplySide West Trade Show

WHAT: Natural Health Science (NHS) is introducing ground breaking clinical research on Pycnogenol® and cholesterol reduction at the Supply Side West International Trade Show and Conference.

A separate educational seminar presented by Dr. Ronald Watson titled Nutraceuticals Reduce Risk Factors for Heart Disease, Asthma and Skin Cancer, will be held on December 5 at 10 a.m. –10:50 a.m. in room 501-502. Dr. Watson, professor of public health and nutritional sciences at the University of Arizona Medical, Public Health and Agriculture Schools, will discuss his recent research findings on Pycnogenol® (French maritime pine bark) and it’s ability to filter out UV rays that cause skin cancer. Dr. Watson also will discuss his research on asthma and Pycnogenol®.

Natural Health Science is sponsoring the Opening Reception, on Thursday, December 5 at SupplySide West. Please join them for this special reception after the exhibit hall closes on opening day from 5:30 p.m.-7:30 p.m.

WHO: Ronald R. Watson, Ph.D., Nutrition and Health Research Expert, was among the first US researchers to investigate the health benefits of Pycnogenol® and has had three peer reviewed publications on the heart, asthma and skin benefits that Pycnogenol® offers. Dr. Watson will be leading the aforementioned seminar.

Frank Schonlau, Ph.D., Director of Scientific Communication for Horphag Research/NHS, Dr. Schonlau will be available to discuss new clinical research on Pycnogenol® and Cholesterol Reduction.

WHERE: Natural Health Science Booth #1586-1588
Supply Side West International Trade Show and Conference
The Venetian & The Sands Expo, Las Vegas, NV

WHEN: December 4 - 6, 2002 (Interviews available throughout show. Arranged times preferred.)


Natural Health Science, LLC, (NHS) based in Hillside, New Jersey, is the North American distributor for Pycnogenol® brand French Maritime Pine Bark Extract on behalf of Horphag Research. Pycnogenol is a registered trademark of Horphag Research Ltd., Guernsey, and its applications are protected by U.S. patents #4,698,360 / #5,720,956 / # 6,372.266 and other international patents. NHS has the exclusive rights to market and sell Pycnogenol® (pic-noj-en-all) and benefits from over thirty years of scientific research assuring the safety and efficacy of Pycnogenol® as a dietary supplement. For more information about Pycnogenol® visit our web site at

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.